Bringing the fundamentals into focus…
Back to Travere Therapeutics, Inc.
How Travere Therapeutics, Inc. stacks up
TVTX · against 245 other Healthcare companies of similar size
Profitability
34/ 100
Below the middle of the pack.
Ranked #181 of 246 · scores higher than 27% of peers
Bars: peers in each 10-point band of the profitability score12 peers with a profitability score of 30–39, including TVTX · Click a bar to see the companies
Why profitability scores 34?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 72% of peers. Operating margin: -6.8% vs peer median 7.1%
- a lower return on assets: weaker than 71% of peers. Return on assets: -5.4% vs peer median 1.7%
- Return on invested capital is close to the peer norm. Return on invested capital: 7.2% vs peer median 4.7%
Metric by metric
Position: dot = TVTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TVTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 239 reported | 7.2% | 7.9% | 47% | 33% | |
| Operating marginHigher is better · 224 reported | -6.8% | 10.9% | 18% | 33% | |
| Return on assetsHigher is better · 235 reported | -5.4% | 2.9% | 26% | 33% | |
| Return on equityHigher is better · 230 reported | -236.4% | 7.5% | 4% | Context only | |
| Gross marginHigher is better · 253 reported | 59.2% | 49.0% | 64% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around TVTX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 3 | 3.8B USD | 99 | 71 | |
| 3 | 2.7B USD | 99 | 84 | |
| 176 | 2.5B USD | 38 | 32 | |
| 178 | 20.7B CNY (≈$2.9B) | 37 | 51 | |
| 179 | 8.6B USD | 36 | 30 | |
| 179 | 2.6B USD | 36 | 32 | |
| 181 | 4.7B USD | 34 | 42 | |
| 182 | 17.6B CNY (≈$2.5B) | 32 | 11 | |
| 183 | 24.9B CNY (≈$3.5B) | 31 | 38 | |
| 183 | 5.3B USD | 31 | 50 | |
| 185 | 2.8B USD | 30 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score